GSK Makes New Adult Immunization Push, Seeks Reimbursement Changes Following RSV Approvals

From ACIP to Part D to data transparency, GSK has several policy asks as it prepares to launch its new RSV vaccine for older adults. The Pink Sheet spoke with GSK’s vaccine policy lead about the firm’s new data platform and the worrisome US vaccination trends following the Covid pandemic.

doctor and patient
GSK wants seniors to be able to get Medicare Part D vaccines in physician offices. • Source: Shutterstock

GSK plcis pushing for policy changes that would make it easier for US seniors to get its new respiratory syncytial virus (RSV) at their physician’s offices ahead of the Centers for Disease Control and Prevention’s review of the vaccine later this month.

Key Takeaways
  • Adult vaccination schedule is getting more complicated and crowded which, could impact uptake of some or all vaccines as US still struggles to return to pre-COVID vaccination rates.

The payment reform request is just one of a handful of efforts GSK is working on as part of its...

More from Vaccines

More from Pink Sheet